Screening Trials
7
Philip C. Prorok,
Philip C. Prorok
National Institutes of Health, Bethesda, MD, USA
Search for more papers by this authorPhilip C. Prorok,
Philip C. Prorok
National Institutes of Health, Bethesda, MD, USA
Search for more papers by this authorFirst published: 15 July 2005
No abstract is available for this article.
References
- 1 Chamberlain, J. (1984). Planning of screening programs for evaluation and non-randomized approaches to evaluation, in Screening For Cancer. I-General Principles on Evaluation of Screening for Cancer and Screening for Lung, Bladder and Oral Cancer, P. C. Prorok & A. B. Miller, eds. UICC Technical Report Series, Vol. 78, International Union Against Cancer, Geneva, pp. 5–17.
- 2 Chu, K. C., Smart, C. R. & Tarone, R. E. (1988). Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial, Journal of the National Cancer Institute 80, 1125–1132.
- 3 Connor, R. J. & Prorok, P. C. (1994). Issues in the mortality analysis of randomized controlled trials of cancer screening, Controlled Clinical Trials 15, 81–99.
- 4 Connor, R. J., Chu, K. C. & Smart, C. R. (1989). Stage-shift cancer screening model, Journal of Clinical Epidemiology 42, 1083–1095.
- 5 Day, N. E., Williams, D. R. R. & Khaw, K. T. (1989). Breast cancer screening programs: the development of a monitoring and evaluation system, British Journal of Cancer 59, 954–958.
- 6 Eddy, D. M. (1980). Screening for Cancer—Theory, Analysis and Design. Prentice-Hall, Englewood Cliffs.
- 7 Eddy, D. M., Hasselblad, V., McGivney, W. & Hendee, W. (1988). The value of mammography screening in women under age 50 years, Journal of the American Medical Association 259, 1512–1519.
- 8 Etzioni, R. & Self, S. G. (1995). On the catch-up time method for analyzing cancer screening trials, Biometrics 51, 31–43.
- 9 Etzioni, R. D., Connor, R. J., Prorok, P. C. & Self, S. G. (1995). Design and analysis of cancer screening trials, Statistical Methods in Medical Research 4, 3–17.
- 10
Fontana, R. S.
(1986).
Screening for lung cancer: recent experience in the United States, in
Lung Cancer: Basic and Clinical Aspects,
H. H. Hansen, ed.
Martinus Nijhoff,
Boston,
pp. 91–111.
10.1007/978-1-4613-2295-5_6 Google Scholar
- 11 Freedman, L. S. & Green, S. B. (1990). Statistical designs for investigating several interventions in the same study: methods for cancer prevention trials, Journal of the National Cancer Institute 82, 910–914.
- 12 Freedman, L. S. & Spiegelhalter, D. J. (1989). Comparison of Bayesian with group sequential methods for monitoring clinical trials, Controlled Clinical Trials 10, 357–367.
- 13 Frisell, J., Eklund, G., Hellstrom, L., Glas, U. & Somell, A. (1989). The Stockholm breast cancer screening trial—5-year results and stage at discovery, Breast Cancer Research Treatment 13, 79–87.
- 14 Gilbertsen, V. A., Church, T. R., Grewe, F. A., Mandel, J. S., McHugh, R. M., Schuman, L. M. & Williams, S. E. (1980). The design of a study to assess occult-blood screening for colon cancer, Journal of Chronic Diseases 33, 107–114.
- 15 Gohagan, J. K., Prorok, P. C., Kramer, B. S., Cornett, J. E. (1994). Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. Journal of Urology 152, 1905–1909.
- 16 Habbema, J. D. F., Lubbe, J. T. N., Van der Maas, P. J. & Van Oortmarssen, G. J. (1983). A computer simulation approach to the evaluation of mass screening, in Medinfo-83, Bemmel, Ball & Wigertz, eds. IPIF-IMIA, North-Holland, Amsterdam, pp. 1222–1225.
- 17 Kafadar, K. & Prorok, P. C. (1994). A data-analytic approach for estimating lead time and screening benefit based on survival curves in randomized cancer screening trials, Statistics in Medicine 13, 569–586.
- 18 Kirch, R. L. A. & Klein, M. (1974). Surveillance schedules for medical examinations, Management Science 20, 1403–1409.
- 19 Knox, E. G. (1973). A simulation system for screening procedures, in The Future and Present Indicatives, Problems and Progress in Medical Care, G. McLachlan, ed. Ninth Series, Nuffield Provincial Hospitals Trust. Oxford University Press, London, pp. 17–55.
- 20 Lan, K. K. G. & De Mets, D. L. (1983). Discrete sequential boundaries for clinical trials, Biometrika 70, 659–663.
- 21
Lan, K. K. G.,
Simon, R. &
Halperin, M.
(1982).
Stochastically curtailed tests in long-term clinical trials,
Communications in Statistics—Sequential Analysis
1,
207–219.
10.1080/07474948208836014 Google Scholar
- 22 Miller, A. B., Howe, G. R. & Wall, C. (1981). The national study of breast cancer screening, Clinical and Investigative Medicine 4, 227–258.
- 23 Morrison, A. S. (1985). Screening in Chronic Disease. Oxford University Press, New York.
- 24 Moss, S. (1994). Personal communication.
- 25 Moss, S., Draper, G. J., Hardcastle, J. D. & Chamberlain, J. (1987). Calculation of sample size in trials of screening for early diagnosis of disease, International Journal of Epidemiology 16, 104–110.
- 26 Petronella, P. G. M., Verbeek, A. L. M. & Straatman, H. (1995). Sample size determination for a trial of breast cancer screening under age 50: population versus case mortality approach, Journal of Medical Screening 2, 90–93.
- 27 Prorok, P. C. (1984). Evaluation of screening programs for the early detection of cancer, in Statistical Methods for Cancer Studies, R. G. Cornell, ed. Marcel Dekker, New York, pp. 267–328.
- 28 Prorok, P. C. (1995). Screening studies, in P. Greenwald, B. S. Kramer & D. L. Weed, eds. Cancer Prevention and Control, Marcel Dekker, New York, pp. 225–242.
- 29 Self, S. G. (1991). An adaptive weighted logrank test with application to cancer prevention and screening trials, Biometrics 47, 975–986.
- 30 Self, S. G. & Etzioni, R. (1995). A likelihood ratio test for cancer screening trials, Biometrics 51, 44–50.
- 31 Shapiro, S., Goldberg, J. D. & Hutchison, G. B. (1974). Lead time in breast cancer detection and implications for periodicity of screening, American Journal of Epidemiology 100, 357–366.
- 32 Shapiro, S., Venet, W., Strax, P. & Venet, L. (1988). Periodic Screening for Breast Cancer. The Health Insurance Plan Project and Its Sequelae, 1963–1986. The Johns Hopkins University Press, Baltimore.
- 33 Shapiro, S., Venet, W., Strax, P., Venet, L. & Roeser, R. (1982). Ten- to fourteen-year effect of screening on breast cancer mortality, Journal of the National Cancer Institute 69, 349–355.
- 34 Shiue, W. K. & Bain, L. J. (1982). Experiment size and power comparisons for two-sample Poisson tests. Applied Statistics 31, 130–134.
- 35 Tabar, L., Fagerberg, G., Duffy, S. W., Day, N. E., Gad, A. & Grontoft, O. (1992). Update of the Swedish two-county program of mammographic screening for breast cancer, Radiologic Clinics of North America 30, 187–210.
- 36
Taylor, W. F. &
Fontana, R. S.
(1972).
Biometric design of the Mayo lung project for early detection and localization of bronchogenic carcinoma,
Cancer
30,
1344–1347.
10.1002/1097-0142(197211)30:5<1344::AID-CNCR2820300530>3.0.CO;2-6 CAS PubMed Web of Science® Google Scholar
- 37
van Oortmarssen, G. J.,
Habbema, J. D. F.,
van der Maas, P. J.,
de Koning, H. J.,
Collette, H. J. A.,
Verbeek, A. L. M.,
Geerts, A. T. &
Lubbe, K. T. N.
(1990).
A model for breast cancer screening,
Cancer
66,
1601–1612.
10.1002/1097-0142(19901001)66:7<1601::AID-CNCR2820660727>3.0.CO;2-O PubMed Web of Science® Google Scholar
- 38 Walter, S. D. & Day, N. E. (1983). Estimation of the duration of a preclinical disease state using screening data, American Journal of Epidemiology 118, 865–886.
- 39 Walter, S. D. & Stitt, L. W. (1987). Evaluating the survival of cancer cases detected by screening, Statistics in Medicine 6, 885–900.
- 40 Xu, J. L. & Prorok, P. C. (1995). Non-parametric estimation of the postlead time survival distribution of screen detected cancer cases, Statistics in Medicine 14, 2715–2725.
- 41 Zelen, M. & Feinleib, M. (1969). On the theory of screening for chronic diseases, Biometrika 56, 601–613.
- 42 Zucker, D. M. & Lakatos, E. (1990). Weighted logrank-type statistics for comparing survival curves when there is a time lag in the effectiveness of treatment, Biometrika 77, 853–864.
